🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This 2 arm study will compare the resection rate of liver metastases and sa...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00778102
Treatments Being Tested
The main aim of the study is to check gene change in tumor tissues with an ...
Status
Active Not Recruiting
Location
Takeda selected site
Start Date
2021-08-31
Trial ID
NCT05030493
Treatments Being Tested
This is a prospective, multicenter, randomized, placebo-controlled, triple-...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02856867
Treatments Being Tested
This phase I trial is to find out the best dose, possible benefits, and/or ...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2021-04-02
Trial ID
NCT04761614
Treatments Being Tested
Phase II study of simultaneous infusion of levozolinate for injection and 5...
Status
Recruiting
Location
Chinese PLA General Hospital, Beijing
Start Date
2025-05-15
Trial ID
NCT07391618
Treatments Being Tested
This is a Phase I, open-label, dose escalation study of ASLAN001 given in c...
Status
Unknown
Location
National Cancer Centre
Start Date
2014-08
Trial ID
NCT02435927
Treatments Being Tested
the aim of this study is to observe the effect of irinotecan-based regimen ...
Status
Unknown
Location
the first affiliated hospital of Sun Yat-sen University
Start Date
2012-06
Trial ID
NCT01566942
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as fluorouracil, oxaliplatin, a...
Status
Completed
Location
Cancer Care of Western North Carolina
Start Date
2010-02
Trial ID
NCT01164215
Treatments Being Tested
This study was designed as multi-center, ambispective observational trial t...
Status
Unknown
Location
Qilu hospital of Shandong University
Start Date
2023-06-01
Trial ID
NCT06322147
Treatments Being Tested
This study determined the maximum tolerated dose and safety of SU011248 (su...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-09
Trial ID
NCT00599924